
Amanda Marie Haney
Examiner (ID: 15654, Phone: (571)272-8668 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1634, 1682 |
| Total Applications | 1025 |
| Issued Applications | 286 |
| Pending Applications | 134 |
| Abandoned Applications | 624 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20093719
[patent_doc_number] => 20250223655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-10
[patent_title] => METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY
[patent_app_type] => utility
[patent_app_number] => 19/088496
[patent_app_country] => US
[patent_app_date] => 2025-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19088496
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/088496 | METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY | Mar 23, 2025 | Pending |
Array
(
[id] => 20093692
[patent_doc_number] => 20250223628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-10
[patent_title] => METHODS OF IMPROVING SURVIVAL AND ELIMINATING TREATMENT-LIMITING TOXICITIES OF DICHLOROACETATE IN PATIENTS WITH PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY
[patent_app_type] => utility
[patent_app_number] => 19/012392
[patent_app_country] => US
[patent_app_date] => 2025-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19012392
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/012392 | METHODS OF IMPROVING SURVIVAL AND ELIMINATING TREATMENT-LIMITING TOXICITIES OF DICHLOROACETATE IN PATIENTS WITH PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY | Jan 6, 2025 | Pending |
Array
(
[id] => 19449303
[patent_doc_number] => 20240309433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => METHOD FOR EVALUATING TEA PLANT (+)-CATECHIN CONTENT
[patent_app_type] => utility
[patent_app_number] => 18/662886
[patent_app_country] => US
[patent_app_date] => 2024-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662886
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/662886 | Method for evaluating tea plant (+)-catechin content | May 12, 2024 | Issued |
Array
(
[id] => 19449332
[patent_doc_number] => 20240309462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => METHOD FOR DETERMINING THE LIKELIHOOD THAT A SUBJECT HAS OR WILL DEVELOP CANCER
[patent_app_type] => utility
[patent_app_number] => 18/657581
[patent_app_country] => US
[patent_app_date] => 2024-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19527
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18657581
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/657581 | METHOD FOR DETERMINING THE LIKELIHOOD THAT A SUBJECT HAS OR WILL DEVELOP CANCER | May 6, 2024 | Pending |
Array
(
[id] => 19218261
[patent_doc_number] => 20240182965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => System and Method for Sequencing
[patent_app_type] => utility
[patent_app_number] => 18/437474
[patent_app_country] => US
[patent_app_date] => 2024-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63852
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18437474
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/437474 | System and Method for Sequencing | Feb 8, 2024 | Pending |
Array
(
[id] => 19528629
[patent_doc_number] => 20240352531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => METHOD FOR DETECTING CD19 EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 18/432678
[patent_app_country] => US
[patent_app_date] => 2024-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5001
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18432678
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/432678 | METHOD FOR DETECTING CD19 EXPRESSION | Feb 4, 2024 | Pending |
Array
(
[id] => 19513330
[patent_doc_number] => 20240345016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => IMPEDANCE-BASED LIQUID BIOPSY SYSTEM AND METHOD FOR DETECTING AND SCREENING CANCER
[patent_app_type] => utility
[patent_app_number] => 18/683145
[patent_app_country] => US
[patent_app_date] => 2024-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18683145
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/683145 | IMPEDANCE-BASED LIQUID BIOPSY SYSTEM AND METHOD FOR DETECTING AND SCREENING CANCER | Jan 28, 2024 | Pending |
Array
(
[id] => 19556901
[patent_doc_number] => 20240368693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => METHOD AND SYSTEM FOR RISK ASSESSMENT OF AUTISM SPECTRUM DISORDER IN A SUBJECT
[patent_app_type] => utility
[patent_app_number] => 18/422276
[patent_app_country] => US
[patent_app_date] => 2024-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15604
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18422276
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/422276 | METHOD AND SYSTEM FOR RISK ASSESSMENT OF AUTISM SPECTRUM DISORDER IN A SUBJECT | Jan 24, 2024 | Pending |
Array
(
[id] => 20173261
[patent_doc_number] => 12391995
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Epigenetic markers and related methods and means for the detection and management of certain cancers
[patent_app_type] => utility
[patent_app_number] => 18/418913
[patent_app_country] => US
[patent_app_date] => 2024-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 21
[patent_no_of_words] => 44300
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 330
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18418913
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/418913 | Epigenetic markers and related methods and means for the detection and management of certain cancers | Jan 21, 2024 | Issued |
Array
(
[id] => 19281990
[patent_doc_number] => 20240218464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => DNA BARCODE FOR SCREENING FLOCCULARIA LUTEOVIRENS WITH HIGH TOTAL FAT CONTENT
[patent_app_type] => utility
[patent_app_number] => 18/418417
[patent_app_country] => US
[patent_app_date] => 2024-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4364
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18418417
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/418417 | DNA BARCODE FOR SCREENING FLOCCULARIA LUTEOVIRENS WITH HIGH TOTAL FAT CONTENT | Jan 21, 2024 | Pending |
Array
(
[id] => 19404067
[patent_doc_number] => 20240287578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => CONCURRENT SEQUENCING OF FORWARD AND REVERSE COMPLEMENT STRANDS ON CONCATENATED POLYNUCLEOTIDES FOR METHYLATION DETECTION
[patent_app_type] => utility
[patent_app_number] => 18/413996
[patent_app_country] => US
[patent_app_date] => 2024-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18413996
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/413996 | CONCURRENT SEQUENCING OF FORWARD AND REVERSE COMPLEMENT STRANDS ON CONCATENATED POLYNUCLEOTIDES FOR METHYLATION DETECTION | Jan 15, 2024 | Pending |
Array
(
[id] => 19710528
[patent_doc_number] => 20250020670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => PERSONALIZED MEDICINE APPROACH FOR TREATING COGNITIVE LOSS
[patent_app_type] => utility
[patent_app_number] => 18/412046
[patent_app_country] => US
[patent_app_date] => 2024-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21346
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18412046
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/412046 | PERSONALIZED MEDICINE APPROACH FOR TREATING COGNITIVE LOSS | Jan 11, 2024 | Abandoned |
Array
(
[id] => 19631540
[patent_doc_number] => 20240409989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => METHODS FOR ASSESSING RISK USING TOTAL AND SPECIFIC CELL-FREE DNA
[patent_app_type] => utility
[patent_app_number] => 18/404829
[patent_app_country] => US
[patent_app_date] => 2024-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18404829
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/404829 | METHODS FOR ASSESSING RISK USING TOTAL AND SPECIFIC CELL-FREE DNA | Jan 3, 2024 | Pending |
Array
(
[id] => 19332883
[patent_doc_number] => 20240247313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => SEROTONIN TRANSPORTER GENE AND TREATMENT OF OPIOID-RELATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/394729
[patent_app_country] => US
[patent_app_date] => 2023-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37812
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18394729
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/394729 | Serotonin transporter gene and treatment of opioid-related disorders | Dec 21, 2023 | Issued |
Array
(
[id] => 20329985
[patent_doc_number] => 12460252
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => MLH1 methylation assay
[patent_app_type] => utility
[patent_app_number] => 18/535773
[patent_app_country] => US
[patent_app_date] => 2023-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 7
[patent_no_of_words] => 9235
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 480
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18535773
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/535773 | MLH1 methylation assay | Dec 10, 2023 | Issued |
Array
(
[id] => 19345598
[patent_doc_number] => 20240254561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => METHODS OF IDENTIFYING AND TREATING TUMORS WITH SIGMA1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/527076
[patent_app_country] => US
[patent_app_date] => 2023-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18527076
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/527076 | METHODS OF IDENTIFYING AND TREATING TUMORS WITH SIGMA1 INHIBITORS | Nov 30, 2023 | Pending |
Array
(
[id] => 19404919
[patent_doc_number] => 20240288430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 18/513107
[patent_app_country] => US
[patent_app_date] => 2023-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18513107
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/513107 | THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER | Nov 16, 2023 | Abandoned |
Array
(
[id] => 19188182
[patent_doc_number] => 20240167095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => METHODS AND COMPOSITIONS FOR PREDICTING TOLERANCE IN TRANSPLANT PATIENTS
[patent_app_type] => utility
[patent_app_number] => 18/511249
[patent_app_country] => US
[patent_app_date] => 2023-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18511249
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/511249 | METHODS AND COMPOSITIONS FOR PREDICTING TOLERANCE IN TRANSPLANT PATIENTS | Nov 15, 2023 | Pending |
Array
(
[id] => 19083447
[patent_doc_number] => 20240110248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => EXTRACT FROM A BODY FLUID COMPRISING A MICRO RNA
[patent_app_type] => utility
[patent_app_number] => 18/379355
[patent_app_country] => US
[patent_app_date] => 2023-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18379355
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/379355 | Extract from a body fluid comprising a micro RNA | Oct 11, 2023 | Issued |
Array
(
[id] => 20433441
[patent_doc_number] => 12503733
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-23
[patent_title] => Methods of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease
[patent_app_type] => utility
[patent_app_number] => 18/240789
[patent_app_country] => US
[patent_app_date] => 2023-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 47277
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18240789
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/240789 | Methods of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease | Aug 30, 2023 | Issued |